Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

TADAWUL:4015 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	183.33	261.67	284.28	141.18	112.63	235.55
Short-Term Investments	-	0.69	0.8	1.06	39.36	20.53
Trading Asset Securities	0.56	0.64	5.16	5.12	-	-
Cash & Short-Term Investments	183.89	263	290.24	147.36	151.99	256.08
Cash Growth	14.00%	-9.38%	96.96%	-3.05%	-40.65%	27.55%
Accounts Receivable	796.95	443.52	332.13	352.36	366.9	418.22
Other Receivables	-	29.77	22.68	28.59	20.58	18.02
Receivables	796.95	473.29	360.62	389.27	404.93	454.72
Inventory	266.29	270.88	233.92	131.86	135.17	129.2
Prepaid Expenses	65.28	4.57	3.99	4.52	3.09	2.54
Other Current Assets	-	16.95	17.93	15.08	4.48	4.17
Total Current Assets	1,312	1,029	906.7	688.08	699.67	846.71
Property, Plant & Equipment	694.73	673.93	698.3	705.05	713.87	613.56
Long-Term Investments	61.21	57.49	36.11	0.25	3.97	3.83
Other Intangible Assets	14.2	11.53	13.05	14.43	14.79	16.54
Other Long-Term Assets	-	-	-	-	-	15.02
Total Assets	2,083	1,772	1,654	1,408	1,432	1,496
Accounts Payable	292.83	42.61	67.98	39.79	41.81	41.9
Accrued Expenses	-	104.19	66.75	51.98	59.55	46.15
Current Portion of Long-Term Debt	-	-	-	-	-	95.02
Current Portion of Leases	0.76	0.26	0.25	0.24	0.25	0.26
Current Income Taxes Payable	19.44	28.8	25.51	17.72	19.74	20.59
Current Unearned Revenue	-	2.14	3.77	-	-	-
Other Current Liabilities	-	23.76	15.72	17.27	17.01	35.15
Total Current Liabilities	313.04	201.76	179.97	126.99	138.36	239.07
Long-Term Leases	3.28	1.83	2.16	2.4	1.72	1.97
Total Liabilities	400.76	281.03	249.84	191.55	200.66	316.59
Common Stock	700	700	700	700	100	100
Retained Earnings	1,138	950.81	811.99	591.35	1,170	1,113
Comprehensive Income & Other	-155.88	-160.21	-107.66	-75.08	-37.88	-33.73
Total Common Equity	1,682	1,491	1,404	1,216	1,232	1,179
Shareholders' Equity	1,682	1,491	1,404	1,216	1,232	1,179
Total Liabilities & Equity	2,083	1,772	1,654	1,408	1,432	1,496
Total Debt	4.05	2.09	2.4	2.64	1.97	97.24
Net Cash (Debt)	179.85	260.91	287.84	144.72	150.03	158.84
Net Cash Growth	12.99%	-9.36%	98.89%	-3.53%	-5.55%	-3.45%
Net Cash Per Share	2.57	3.73	4.11	2.07	15.00	15.88
Filing Date Shares Outstanding	70	70	70	70	10	10
Total Common Shares Outstanding	70	70	70	70	10	10
Working Capital	999.38	826.92	726.73	561.09	561.3	607.64
Book Value Per Share	24.03	21.29	20.06	17.38	123.16	117.91
Tangible Book Value	1,668	1,479	1,391	1,202	1,217	1,163
Tangible Book Value Per Share	23.82	21.13	19.88	17.17	121.68	116.25
Land	58.6	58.56	59.73	60.46	62.59	62.58
Buildings	272.64	271.46	224.31	177.98	176.67	153.84
Machinery	767.75	719.15	564.16	515.41	510.48	488.57
Construction In Progress	34.16	59.53	252.89	329.94	325.12	249.46

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.